{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-026883","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2025-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.558747+00:00","generated_at":"2026-05-16T13:54:11.019300+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncotelic closes initial 11 units of up to 500-unit offering with 12% notes and warrants","bullets":["Initial closing of 11 units at $25,000 each in best-efforts offering of up to 500 units.","Each unit includes a $25,000 note bearing 12% annual interest, due 2 years after final closing.","Notes convertible into OTLC common at $0.10/share or EdgePoint AI common at $1.00/share.","Each unit includes 250,000 warrants to buy OTLC common at $0.12/share or 25,000 EdgePoint warrants at $1.25/share.","Minimum of 10 units required; funds held in escrow until minimum met; offering exempt under Reg D Rule 506."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-026883","json":"https://secwatch.observer/filing/0001493152-25-026883.json","markdown":"https://secwatch.observer/filing/0001493152-25-026883.md","text":"https://secwatch.observer/filing/0001493152-25-026883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/0001493152-25-026883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315225026883/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:54:11.019300+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}